Objective: We conducted a comparative proteomic analysis of placental and umbilical cord blood proteins using surface-enhanced laser desorption ionization-time of flight mass spectrometry (SELDITOF MS) to examine the associations among asthma, fetal gender, and protein profiles.
Methods: Placental tissue and umbilical vein plasma were collected from 10 healthy and 20 asthmatic women. Placental proteins were extracted using phosphate-buffered saline containing protease inhibitors. Samples were applied to the surfaces of strong anion exchange (SAX2), weak cation exchange (WCX2) and immobilized metal affinity capture (IMAC-Cu2+) chips. Mass analysis was conducted using a Ciphergen Protein Biology System IIc (Freemont, CA), and differences in individual peak intensities between groups were determined.
Results: Fourteen placental peaks were significantly different between asthmatic and non-asthmatic women (seven more highly expressed and seven less highly expressed). Ten umbilical cord blood peak differences were identified, with four peaks more highly expressed and six peaks less highly expressed in asthmatics. Four placental and three umbilical cord blood proteins differed significantly between male and female fetuses. Two placental and five umbilical cord blood peaks were specifically increased in a subgroup of samples collected from asthmatic women who did not use inhaled glucocorticoids and were pregnant with a female fetus, a group previously found to have altered placental function.
Conclusions: This study demonstrates the abilities of the SELDI technique as a tool for protein profiling in tissue or plasma. Further work to positively identify the candidate peptides found in this study may provide a greater understanding of the placental mechanisms leading to alterations in fetal growth in patients with bronchial asthma.
1. Williams KL. Genomes and proteomes: Towards a multidimensional view of biology. Electrophoresis1999;20:678-688.
2.
2. Brewis IA. Proteomics in reproductive research: the potential importance of proteomics to research in reproduction. Hum Reprod1999;14:2927-2929.
3.
3. Romero R, Kuivaniemi H, Tromp G. Functional genomics and proteomics in term and preterm parturition. J Clin Endocrinol Metab2002;87:2431-2434.
4.
4. Page NM, Kemp CF, Butlin DJ, Lowry PJ. Placental peptides as markers of gestational disease. Reproduction2002;123:487-495.
5.
5. Vuadens F, Benay C, Crettaz D, et al. Identification of biologic markers of the premature rupture of fetal membranes: Proteomic approach. Proteomics2003;3:1521-1525.
6.
6. Batorfi J, Ye B, Mok SC, Cseh I, Berkowitz RS, Fulop V. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol Oncol2003;88:424-428.
7.
7. Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom1993;7:576-580.
8.
8. Weinberger SR, Dalmasso EA, Fung ET. Current achievements using ProteinChip Array technology. Curr Opin Chem Biol2002;6:86-91.
9.
9. Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer2003;3:267-275.
10.
10. Issaq HJ, Veenstra TD, Conrads TP, Felschow D. The SELDITOF MS approach to proteomics: Protein profiling and biomarker identification. Biochem Biophys Res Commun2002;292: 587-592.
11.
11. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis2000; 21:1164-1177.
12.
12. Caputo E, Moharram R, Martin BM. Methods for on-chip protein analysis. Anal Biochem2003;321:116-124.
13.
13. Kurinczuk JJ, Parsons DE, Dawes V, Burton PR. The relationship between asthma and smoking during pregnancy. Women Health1999;29:31-47.
14.
14. Kwon HL, Belanger K, Bracken MB. Asthma prevalence among pregnant and childbearing-aged women in the United States: Estimates from national health surveys. Ann Epidemiol2003;13:317-324.
15.
15. Gardner MJ, Schatz M, Cousins L, Zeiger R, Middleton E, Jusko WJ. Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol1987;32:289-295.
16.
16. Bracken MB, Triche EW, Belanger K, Saftlas A, Beckett WS, Leaderer BP. Asthma symptoms, severity, and drug therapy: A prospective study of effects on 2205 pregnancies. Obstet Gynecol2003;102:739-752.
17.
17. Dombrowski MP, Schatz M, Wise R, et al. Asthma during pregnancy. Obstet Gynecol2004;103:5-12.
18.
18. Triche EW, Saftlas AF, Belanger K, Leaderer BP, Bracken MB. Association of asthma diagnosis, severity, symptoms, and treatment with risk of preeclampsia. Obstet Gynecol2004;104: 585-593.
19.
19. Murphy VE, Gibson PG, Giles WB, et al. Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med2003;168:1317-1323.
20.
20. Murphy VE, Zakar T, Smith R, Giles WB, Gibson PG, Clifton VL. Reduced 1lbeta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol Metab2002;87:1660-1668.
21.
21. Clifton VL, Murphy VE. Maternal asthma as a model for examining fetal sex-specific effects on maternal physiology and placental mechanisms that regulate human fetal growth. Placenta2004;25Suppl A:S45-S52.
22.
22. Asthma Management Handbook. South Melbourne, Australia: National Asthma Council Australia Ltd, 2002.
23.
23. National Institute of Health: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung and Blood Institute, 1997.
24.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem1976;72:248-254.
25.
25. Clifton VL, Giles W.B, Smith R, et al. Alterations of placental vascular function in asthmatic pregnancies. Am J Respir Crit Care Med2001;164:546-553.
26.
26. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics2004;20:777-785.
